BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

731 related articles for article (PubMed ID: 29025653)

  • 1. Stepwise pH/reduction-responsive polymeric conjugates for enhanced drug delivery to tumor.
    Yang S; Wang Y; Ren Z; Chen M; Chen W; Zhang X
    Mater Sci Eng C Mater Biol Appl; 2018 Jan; 82():234-243. PubMed ID: 29025653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced Cellular Internalization and On-Demand Intracellular Release of Doxorubicin by Stepwise pH-/Reduction-Responsive Nanoparticles.
    Li F; Chen WL; You BG; Liu Y; Yang SD; Yuan ZQ; Zhu WJ; Li JZ; Qu CX; Zhou YJ; Zhou XF; Liu C; Zhang XN
    ACS Appl Mater Interfaces; 2016 Nov; 8(47):32146-32158. PubMed ID: 27933846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Facile preparation of core cross-linked nanomicelles based on graft copolymers with pH responsivity and reduction sensitivity for doxorubicin delivery.
    Chen T; Xiao Y; Lu W; Liu S; Gan L; Yu J; Huang J
    Colloids Surf B Biointerfaces; 2018 Jan; 161():606-613. PubMed ID: 29156337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PEG-Detachable Polymeric Micelles Self-Assembled from Amphiphilic Copolymers for Tumor-Acidity-Triggered Drug Delivery and Controlled Release.
    Xu M; Zhang CY; Wu J; Zhou H; Bai R; Shen Z; Deng F; Liu Y; Liu J
    ACS Appl Mater Interfaces; 2019 Feb; 11(6):5701-5713. PubMed ID: 30644711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. pH-triggered charge-reversal and redox-sensitive drug-release polymer micelles codeliver doxorubicin and triptolide for prostate tumor therapy.
    Xu C; Song RJ; Lu P; Chen JC; Zhou YQ; Shen G; Jiang MJ; Zhang W
    Int J Nanomedicine; 2018; 13():7229-7249. PubMed ID: 30510415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction-responsive disassemblable core-cross-linked micelles based on poly(ethylene glycol)-b-poly(N-2-hydroxypropyl methacrylamide)-lipoic acid conjugates for triggered intracellular anticancer drug release.
    Wei R; Cheng L; Zheng M; Cheng R; Meng F; Deng C; Zhong Z
    Biomacromolecules; 2012 Aug; 13(8):2429-38. PubMed ID: 22746534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. pH/redox dual-responsive amphiphilic zwitterionic polymers with a precisely controlled structure as anti-cancer drug carriers.
    Wu Z; Gan Z; Chen B; Chen F; Cao J; Luo X
    Biomater Sci; 2019 Aug; 7(8):3190-3203. PubMed ID: 31145392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2,2'-Dithiodisuccinic acid-stabilized polyion complex micelles for pH and reduction dual-responsive drug delivery.
    Du Y; Yan W; Lian H; Xiang C; Duan L; Xiao C
    J Colloid Interface Sci; 2018 Jul; 522():74-81. PubMed ID: 29579564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coordinated pH/redox dual-sensitive and hepatoma-targeted multifunctional polymeric micelle system for stimuli-triggered doxorubicin release: Synthesis, characterization and in vitro evaluation.
    Wang L; Tian B; Zhang J; Li K; Liang Y; Sun Y; Ding Y; Han J
    Int J Pharm; 2016 Mar; 501(1-2):221-35. PubMed ID: 26851356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poly(ethylene glycol) shell-sheddable TAT-modified core cross-linked nano-micelles: TAT-enhanced cellular uptake and lysosomal pH-triggered doxorubicin release.
    Zhang Y; Xiao Y; Huang Y; He Y; Xu Y; Lu W; Yu J
    Colloids Surf B Biointerfaces; 2020 Apr; 188():110772. PubMed ID: 31999965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nucleolin-Targeting AS1411-Aptamer-Modified Graft Polymeric Micelle with Dual pH/Redox Sensitivity Designed To Enhance Tumor Therapy through the Codelivery of Doxorubicin/TLR4 siRNA and Suppression of Invasion.
    Yang S; Ren Z; Chen M; Wang Y; You B; Chen W; Qu C; Liu Y; Zhang X
    Mol Pharm; 2018 Jan; 15(1):314-325. PubMed ID: 29250957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stepwise pH-responsive nanoparticles for enhanced cellular uptake and on-demand intracellular release of doxorubicin.
    Chen WL; Li F; Tang Y; Yang SD; Li JZ; Yuan ZQ; Liu Y; Zhou XF; Liu C; Zhang XN
    Int J Nanomedicine; 2017; 12():4241-4256. PubMed ID: 28652730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Free Adriamycin-Loaded pH/Reduction Dual-Responsive Hyaluronic Acid-Adriamycin Prodrug Micelles for Efficient Cancer Therapy.
    Yin T; Wang Y; Chu X; Fu Y; Wang L; Zhou J; Tang X; Liu J; Huo M
    ACS Appl Mater Interfaces; 2018 Oct; 10(42):35693-35704. PubMed ID: 30259743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Charge-conversional and reduction-sensitive poly(vinyl alcohol) nanogels for enhanced cell uptake and efficient intracellular doxorubicin release.
    Chen W; Achazi K; Schade B; Haag R
    J Control Release; 2015 May; 205():15-24. PubMed ID: 25445693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-delivery of erlotinib and doxorubicin by pH-sensitive charge conversion nanocarrier for synergistic therapy.
    He Y; Su Z; Xue L; Xu H; Zhang C
    J Control Release; 2016 May; 229():80-92. PubMed ID: 26945977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumoral acidic extracellular pH targeting of pH-responsive MPEG-poly(beta-amino ester) block copolymer micelles for cancer therapy.
    Ko J; Park K; Kim YS; Kim MS; Han JK; Kim K; Park RW; Kim IS; Song HK; Lee DS; Kwon IC
    J Control Release; 2007 Nov; 123(2):109-15. PubMed ID: 17894942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A shell-crosslinked polymeric micelle system for pH/redox dual stimuli-triggered DOX on-demand release and enhanced antitumor activity.
    Wang L; Zhang J; Song M; Tian B; Li K; Liang Y; Han J; Wu Z
    Colloids Surf B Biointerfaces; 2017 Apr; 152():1-11. PubMed ID: 28063272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction/temperature/pH multi-stimuli responsive core cross-linked polypeptide hybrid micelles for triggered and intracellular drug release.
    Qu J; Wang QY; Chen KL; Luo JB; Zhou QH; Lin J
    Colloids Surf B Biointerfaces; 2018 Oct; 170():373-381. PubMed ID: 29940504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exogenous Vitamin C-Triggered Surface Charge Conversion of pH/Reduction-Responsive Micelles for the Enhanced Tumor-Specific Activity of Loaded Doxorubicin.
    Wu Z; Chen B; Gan Z; Chen F; Luo X
    Mol Pharm; 2020 Mar; 17(3):954-964. PubMed ID: 31977226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. pH-sensitive doxorubicin-conjugated prodrug micelles with charge-conversion for cancer therapy.
    Ma B; Zhuang W; Wang Y; Luo R; Wang Y
    Acta Biomater; 2018 Apr; 70():186-196. PubMed ID: 29452272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.